{"id":413,"date":"2007-01-31T12:59:00","date_gmt":"2007-01-31T12:59:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=nolato-year-end-report-strong-cash-flow-substantial-growth-for-nolato-medical"},"modified":"2007-01-31T12:59:00","modified_gmt":"2007-01-31T12:59:00","slug":"nolato-year-end-report-strong-cash-flow-substantial-growth-for-nolato-medical","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/de\/mfn_news\/nolato-year-end-report-strong-cash-flow-substantial-growth-for-nolato-medical\/","title":{"rendered":"Nolato year-end report: Strong cash flow \u2013 substantial growth for Nolato Medical"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<pre><p>In today\u2019s year-end report, Nolato posted an increase in sales of 20 percent compared to 2006. EBITA, excluding non-recurring items, was SEK 209 M (221).<br\/>\n<br\/>\n\u2022 Sales increased to SEK 2,702 M (2,256)<br\/>\n\u2022 EBITA excluding non-recurring items was SEK 209 M (221)<br\/>\n\u2022 Non-recurring items totaled SEK 130 M (0)<br\/>\n\u2022 Income after financial items was SEK 69 M (208)<br\/>\n\u2022 Cash flow after investments was SEK 142 M (158) excluding aquisitions<br\/>\n<br\/>\n\u201cNolato Telecom\u2019s sales increased 33 percent and its earnings excluding non-recurring items was SEK 124 M (137). Unfortunately, strong earnings were impaired by a one-time provision of SEK 125 M for our German customer BenQ\u2019s feared bankruptcy,\u201d noted Georg Brunstam, who is President and CEO of Nolato.<br\/>\n<br\/>\nNolato Medical continued its strong growth in 2006 and increased sales 33 percent. Organic growth was 23 percent. The acquisition of Medical Rubber, which was carried out on November 1, proceeded as planned, and the company has had a positive impact on earnings per share since its takeover.<br\/>\n<br\/>\n\u201cThe acquisition is completely in line with our strategic plans and has enhanced Nolato Medical\u2019s position as a leading manufacturer of systems components in medical technology,\u201d added Mr. Brunstam.<br\/>\n<br\/>\nNolato Industrial reported an increase in both sales and income.<br\/>\n<br\/>\n\u201cWe have streamlined production and invested in both Swedish and Hungarian operations. Our investments in the automotive industry have also yielded good results,\u201d Mr. Brunstam said.<br\/>\n<br\/>\nThe Board of Directors proposes an unchanged dividend of SEK 2.40 per share.<br\/>\n<br\/>\nFor the first quarter of 2007, Nolato expects that, given Nolato Telecom\u2019s normal seasonal variation, temporarily low volumes in a major customer project in progress and the loss in sales to BenQ, Nolato Telecom\u2019s sales will decrease 20\u201325 percent compared with the fourth quarter of 2006. Nolato Medical is expected to continue its growth in sales in the first quarter of 2007, while sales at Nolato Industrial are expected to be stable.<br\/>\n<br\/>\nTorekov January 31, 2007<br\/>\nNolato AB (publ)<br\/>\nThe Board of Directors<br\/>\n<\/p><\/pre>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In today\u2019s year-end report, Nolato posted an increase in sales of 20 percent compared to 2006. EBITA, excluding non-recurring items, was SEK 209 M (221). \u2022 Sales increased to SEK 2,702 M (2,256) \u2022 EBITA excluding non-recurring items was SEK 209 M (221) \u2022 Non-recurring items totaled SEK 130 M (0) \u2022 Income after financial&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/de\/mfn_news\/nolato-year-end-report-strong-cash-flow-substantial-growth-for-nolato-medical\/\">Continue reading <span class=\"screen-reader-text\">Nolato year-end report: Strong cash flow \u2013 substantial growth for Nolato Medical<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-413","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-report-interim-q4","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"de","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news\/413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/media?parent=413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}